Scholars Central

Short communicationPublished Jan 2021

Natural killer cell based immunotherapies as cancer therapeutics

Authors: Kawaljit Kaur

Medical Microbiology Reports

Volume 5 · Issue 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Natural killer (NK) cells are known to target cancer cells. Since conventional cancer therapeutics including chemotherapy and radiotherapy remain unsuccessful to completely cure the cancer, there has been increasing demand of immunotherapies to treat cancer. In past few years there has been NK cell-based immunotherapies showed promising results. But, decreased NK cell cytotoxicity has been documented in cancer patients both in peripheral blood and tumour microenvironment. Advances in understanding of anti-tumour immune responses and cancer biology have revealed a complex dynamic interaction between the immune effectors and the tumour cells. Therefore, because of defects in cancer patients’ NK cells, utilizing healthy allogeneic NK cells should be selected as cancer immunotherapeutic.

Subjects

Microbiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Medical Microbiology Reports.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMedical Microbiology Reports
  • SubjectMicrobiology
  • BylineArticles whose byline prints “Kawaljit Kaur”